SKYSCRAPER-03: A Phase III Study of Tiragolumab Plus Atezolizumab Versus Durvalumab in Locally Advanced, Unresectable, Stage III NSCLC After Platinum-Based Concurrent Chemoradiation
1. 系统已在2026-09-11 11:45:19对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/j.annonc.2026.07.414
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S0923753426014547
其他信息:
出版社: Elsevier BV
作者: H.A. Wakelee; M-J. Ahn; J. Bradley; S. Popat; K. Kelly; A-M. Baird; O. Ozyilkan; J. Yu; S.Y. Lee; N. Yanagitani; M. Johnson; A. Sánchez-Hernández; A. Szczesna; K. Cuppens; E. Yao; C. Parsons; C. Matheny; Z. Zhang; M.N. White; J.J. Hsu; N.S. Patil; R. Dziadziuszko

